Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Bioavailability of omega-3 fatty acids (FA) depends on their chemical form. Superior bioavailability has been suggested for phospholipid (PL) bound omega-3 FA in krill oil, but identical doses of different chemical forms have not been compared. METHODS: In a double-blinded crossover trial, we compared the uptake of three EPA+DHA formulations derived from fish oil (re-esterified triacylglycerides [rTAG], ethyl-esters [EE]) and krill oil (mainly PL). Changes of the FA compositions in plasma PL were used as a proxy for bioavailability. Twelve healthy young men (mean age 31 y) were randomized to 1680 mg EPA+DHA given either as rTAG, EE or krill oil. FA levels in plasma PL were analyzed pre-dose and 2, 4, 6, 8, 24, 48, and 72 h after capsule ingestion. Additionally, the proportion of free EPA and DHA in the applied supplements was analyzed. RESULTS: The highest incorporation of EPA+DHA into plasma PL was provoked by krill oil (mean AUC0-72 h: 80.03 ± 34.71%*h), followed by fish oil rTAG (mean AUC0-72 h: 59.78 ± 36.75%*h) and EE (mean AUC0-72 h: 47.53 ± 38.42%*h). Due to high standard deviation values, there were no significant differences for DHA and the sum of EPA+DHA levels between the three treatments. However, a trend (p = 0.057) was observed for the differences in EPA bioavailability. Statistical pair-wise group comparison's revealed a trend (p = 0.086) between rTAG and krill oil. FA analysis of the supplements showed that the krill oil sample contained 22% of the total EPA amount as free EPA and 21% of the total DHA amount as free DHA, while the two fish oil samples did not contain any free FA. CONCLUSION: Further studies with a larger sample size carried out over a longer period are needed to substantiate our findings and to determine differences in EPA+DHA bioavailability between three common chemical forms of LC n-3 FA (rTAG, EE and krill oil). The unexpected high content of free EPA and DHA in krill oil, which might have a significant influence on the availability of EPA+DHA from krill oil, should be investigated in more depth and taken into consideration in future trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount and ratio of EPA and DHA differ in various supplements, resulting in different bioavailability and absorption rates. 142 , 143 , 144”
From Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials (2023) · cites this paper as [142]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The FFA formulation has greater bioavailability compared with the ethyl esters”
From The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk (2019) · cites this paper as [151]
In the citing paper
“In contrast to most other algal food constituents, the bioaccessibility of DHA and EPA in algal-derived oils and extracts is well quantified for humans, ranging from ∼50 to 100 % depending on the matrix (Haug et al. 2011; Schuchardt et al. 2011).”
From Algae as nutritional and functional food sources: revisiting our understanding. (2017) · cites this paper as Schuchardt et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koletzko, B., Lien, E., Agostoni, C., Böhles, H., Campoy, C., Cetin, I., Decsi, T., Dudenhausen, J. W., Dupont, C., Forsyth, S., et al. (2008) · Journal of Perinatal Medicine · doi:10.1515/jpm.2008.001 · Cited by 707
Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie, C. J., Milani, R. V., Mehra, M. R., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.084 · Cited by 644 · cited 1×
“Scientific and regulatory bodies recommend an increased intake of EPA+DHA for cardiovascular prevention or during pregnancy [1-3].”
BackgroundKris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000057393.97337.ae · Cited by 596
Influence of emulsifier type on in vitro digestibility of lipid droplets by pancreatic lipase
Mun, S., Decker, E. A., & McClements, D. J. (2007) · Food Research International · doi:10.1016/j.foodres.2007.01.007 · Cited by 454 · cited 1×
“As a result, PL influence the surface composition of fat droplets, which possibly facilitates the binding of hydrolyzing enzymes and hence the digestion [22].”
BackgroundMori, T. A., Bao, D. Q., Burke, V., Puddey, I. B., & Beilin, L. J. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.253 · Cited by 407 · cited 1×
“Of note, systolic blood pressure declined only in the menhaden oil group, possibly reflecting the fact that DHA, but not EPA, lowers blood pressure [17].”
BackgroundDietary reference intakes for DHA and EPA
Kris-Etherton, P. M., Grieger, J. A., & Etherton, T. D. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.011 · Cited by 404 · cited 1×
“Scientific and regulatory bodies recommend an increased intake of EPA+DHA for cardiovascular prevention or during pregnancy [1-3].”
BackgroundHuman absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters
Lawson, L. D., & Hughes, B. G. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80718-6 · Cited by 359 · cited 2×
“Smaller trials carried out earlier had inconsistent results [8-13].”
ResultUlven, S. M., Kirkhus, B., Lamglait, A., Basu, S., Elind, E., Haider, T., Berge, K., Vik, H., & Pedersen, J. I. (2011) · Lipids · doi:10.1007/s11745-010-3490-4 · Cited by 303 · cited 3×
“[15] analyzed total plasma FA composition, we used changes in plasma PL FA composition after a single dose treatment as a proxy for bioavailability.”
BackgroundMethodInfluentialThe omega-3 index as a risk factor for coronary heart disease
Harris, W. S. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1997s · Cited by 297 · cited 1×
“67 g/d) leads to a faster and higher increase of the omega-3 index - the percentage of EPA and DHA in red cell membranes reflecting the long-term intake and n-3 FA status of an individual [5] - when consumed as rTAG than when consumed as EE [6].”
BackgroundBioavailability of marine n-3 fatty acid formulations
Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.06.007 · Cited by 256 · cited 3×
“Our results were in line with data from a short-term study of two weeks duration measuring the FA compositions of serum cholesterol-esters, TAG and phospholipids (PL): relative bioavailability of EPA+DHA from rTAG was superior (124%) compared with cod liver oil (100%), whereas the bioavailability from EE was inferior…”
BackgroundResultInfluentialMaki, K. C., Reeves, M. S., Farmer, M., Griinari, M., Berge, K., Vik, H., Hubacher, R., & Rains, T. M. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.09.004 · Cited by 192
Davidson, M. H., Johnson, J., Rooney, M. W., Kyle, M. L., & Kling, D. F. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.01.002 · Cited by 191
Intestinal absorption of long-chain fatty acids: Evidence and uncertainties
Niot, I., Poirier, H., Tran, T. T. T., & Besnard, P. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.01.001 · Cited by 181 · cited 1×
“After absorption into enterocytes, the metabolism of LC PUFA involves re-esterification into TAG (2-monoglyceride pathway) and PL (a-glycerophosphate pathway), as well as the formation of chylomicrons for further transport [25,26].”
BackgroundEnteral absorption in man of eicosapentaenoic acid in different chemical forms
Boustani, S. E., Colette, C., Monnier, L., Descomps, B., Crastes de Paulet, A., & Mendy, F. (1987) · Lipids · doi:10.1007/bf02533970 · Cited by 178 · cited 2×
“Smaller trials carried out earlier had inconsistent results [8-13].”
ResultNeubronner, J., Schuchardt, J. P., Kressel, G., Merkel, M., von Schacky, C., & Hahn, A. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.239 · Cited by 173 · cited 1×
“67 g/d) leads to a faster and higher increase of the omega-3 index - the percentage of EPA and DHA in red cell membranes reflecting the long-term intake and n-3 FA status of an individual [5] - when consumed as rTAG than when consumed as EE [6].”
BackgroundSelf-citationMansbach, C. M., & Gorelick, F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00299.2007 · Cited by 170 · cited 1×
“After absorption into enterocytes, the metabolism of LC PUFA involves re-esterification into TAG (2-monoglyceride pathway) and PL (a-glycerophosphate pathway), as well as the formation of chylomicrons for further transport [25,26].”
BackgroundNordøy, A., Barstad, L., CONNOR, W. E., & Hatcher, L. F. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.5.1185 · Cited by 163 · cited 1×
“Smaller trials carried out earlier had inconsistent results [8-13].”
ResultKaminski, W., Jendraschak, E., Kiefl, R., & von Schacky, C. (1993) · Blood · doi:10.1182/blood.v81.7.1871.1871 · Cited by 134
Digestion and absorption of polyunsaturated fatty acids
Carlier, H., Bernard, A., & Caselli, C. (1991) · Reproduction Nutrition Development · doi:10.1051/rnd:19910501 · Cited by 132 · cited 1×
“pPLA2 interacts with PL at the sn-2 position yielding FFA and lyso-phosphatidylcholine, which are absorbed by the enterocytes as parts of mixed micelles [21].”
BackgroundKrokan, H. E., Bjerve, K. S., & Mørk, E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90266-c · Cited by 109 · cited 1×
“Smaller trials carried out earlier had inconsistent results [8-13].”
ResultHuggins, K. W., Boileau, A. C., & Hui, D. Y. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2002 · Cited by 103 · cited 1×
“Studies with pPLA2-KO mice indicates that pPLA2 deficiency does not affect PL hydrolysis and absorption in contrast to TAG [23], possibly because its activity is compensated by other PL hydrolyzing enzymes [24].”
BackgroundRichmond, B. L., Boileau, A. C., Zheng, S., Huggins, K. W., Granholm, N. A., Tso, P., & Hui, D. Y. (2001) · Gastroenterology · doi:10.1053/gast.2001.23254 · Cited by 98 · cited 1×
“Studies with pPLA2-KO mice indicates that pPLA2 deficiency does not affect PL hydrolysis and absorption in contrast to TAG [23], possibly because its activity is compensated by other PL hydrolyzing enzymes [24].”
BackgroundEffects of a convenience drink fortified withn-3 fatty acids on then-3 index
Köhler, A., Bittner, D. O., Löw, A., & von Schacky, C. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001054 · Cited by 86 · cited 1×
“Recently, we demonstrated substantial inter-individual variability in bioavailability of a TAG form of EPA +DHA in a convenience drink [27].”
BackgroundBeckermann, B., Beneke, M., & Seitz, I. (1990) · PubMed · Cited by 61
Hansen, J. B., Olsen, J. O., Wilsgård, L., LYNGMO, V., & Svensson, B. (1993) · PubMed · Cited by 50
Kling, D. F., Johnson, J., Rooney, M., & Davidson, M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.062 · Cited by 23 · cited 1×
“Likewise, a recent study demonstrated a markedly enhanced bioavailability of n-3 FFA over EE in overweight patients on a low-fat diet, which is recommended for patients with hypertriglyceridemia [20].”
BackgroundOmega‐3 Index and cardiovascular disease prevention: principle and rationale
von Schacky, C. (2010) · Lipid Technology · doi:10.1002/lite.201000034 · Cited by 19 · cited 1×
“In terms of LC n-3 FA, red blood cells reflect tissue composition, at least of the heart, but probably also of other organs [18].”
Background
Cited by
Algae as nutritional and functional food sources: revisiting our understanding.
Wells, M. L., Potin, P., Craigie, J. S., Raven, J. A., Merchant, S. S., Helliwell, K. E., Smith, A. G., Camire, M. E., & Brawley, S. H. (2017) · Journal of Applied Phycology · doi:10.1007/s10811-016-0974-5 · Cited by 1,562
“In contrast to most other algal food constituents, the bioaccessibility of DHA and EPA in algal-derived oils and extracts is well quantified for humans, ranging from ∼ 50 to 100 % depending on the matrix (Haug et al. 2011; Schuchardt et al. 2011).”
Omega-3 polyunsaturated fatty acids and their health benefits
Shahidi, F., & Ambigaipalan, P. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111317-095850 · Cited by 1,390
Siscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000482 · Cited by 629
Sandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 608
A Comprehensive Review of Chemistry, Sources and Bioavailability of Omega-3 Fatty Acids
Cholewski, M., Tomczykowa, M., & Tomczyk, M. (2018) · Nutrients · doi:10.3390/nu10111662 · Cited by 372
Metadata
- Authors
- Schuchardt, J., Schneider, I., Meyer, H., Neubronner, J., von Schacky, C., & Hahn, A.
- Affiliations
- Leibniz University Hannover (DE)
- Corresponding author
- Schuchardt, Jan
- Venue
- Lipids in Health and Disease
- Published
- 2011
- Volume
- 10
- Issue
- 1
- Pages
- 145
- ISSN
- 1476-511X (ISSN-L)
- PMC
- PMC3168413
- OpenAlex
- W2142533350
- Cited by
- 291
- References
- 28
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 16 · 2023: 12 · 2022: 15 · 2021: 22 · 2020: 21 · 2019: 26 · 2018: 22 · 2017: 11 · 2016: 21 · 2015: 30 · 2014: 26 · 2013: 27 · 2012: 13
- FWCI
- 19.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Lipids in Health and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
- Leibniz Universität Hannover (cc-by)
- Funders
- Gottfried Wilhelm Leibniz Universität Hannover
- Ludwig-Maximilians-Universität München
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Keywords
- omega-3 fatty acids, EPA, docosahexaenoic acid, bioavailability, krill oil, fish oil, ethyl esters, free fatty acids, plasma phospholipids, n-3 long-chain polyunsaturated fatty acids, dietary supplement formulation, healthy young men, crossover trial
- MeSH terms
- Adult, Animals, Chemistry, Pharmaceutical, Docosahexaenoic Acids, Double-Blind Method, Fish Oils, Humans, Male, Phospholipids, Eicosapentaenoic Acid, Area Under Curve, Euphausiacea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.